Evofem Biosciences (EVFM) Share-based Compensation (2014 - 2026)
Evofem Biosciences (EVFM) recorded Share-based Compensation of $15,000 in Q1 2026, down 78.6% from $70,000 a year earlier and down 64.3% from the prior quarter.
Powered by 
Analysis
Evofem Biosciences (EVFM) Share-based Compensation (2014 - 2026) Analysis & Trends
For FY2025, Evofem Biosciences reported Share-based Compensation of $166,000, down 80.4% from FY2024.
- Annual Share-based Compensation has declined for five straight years, with a five-year compound annual growth rate of -58.0% (FY2020 to FY2025).
- Across earlier years, Share-based Compensation came in at $847,000 in FY2024 (-28.8%), $1.19 million in FY2023 (-64.1%), $3.31 million in FY2022 (-62.8%) and $8.9 million in FY2021 (-29.9%).
- The Q1 2026 figure is the lowest quarterly Share-based Compensation in data going back to Q1 2014.
- On a year-over-year basis, Share-based Compensation has declined for nine consecutive quarters, with an average decline of 58.0% over the last eight quarters.
- Peak year-over-year performance for Share-based Compensation in the last five years was growth of 34.4% in Q4 2023, against a decline of 88.7% in Q3 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at $42,000 (Q4 2025), $23,000 (Q3 2025) and $31,000 (Q2 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,171.06 Bn | 1,139.65 Bn | 19.71 Bn | 201.00 Mn |
| 2 | Johnson & Johnson | 634.89 Bn | 553.42 Bn | 17.26 Bn | 458.00 Mn |
| 3 | AbbVie | 503.32 Bn | 476.44 Bn | 12.70 Bn | 166.00 Mn |
| 4 | Merck | 377.44 Bn | 331.82 Bn | 12.21 Bn | 298.00 Mn |
| 5 | Novartis Ag | 303.91 Bn | 267.90 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 267.03 Bn | 240.72 Bn | 12.86 Bn | - |
| 7 | Amgen | 241.88 Bn | 197.28 Bn | 7.24 Bn | 165.00 Mn |
| 8 | Gilead Sciences | 194.01 Bn | 168.20 Bn | 6.22 Bn | 231.00 Mn |
| 9 | Pfizer | 172.57 Bn | 119.21 Bn | 10.94 Bn | 249.00 Mn |
| 10 | Evofem Biosciences | 1.33 Mn | 1.33 Mn | 2.12 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 15,000.00 |
| Dec 31, 2025 | 42,000.00 |
| Sep 30, 2025 | 23,000.00 |
| Jun 30, 2025 | 31,000.00 |
| Mar 31, 2025 | 70,000.00 |
| Dec 31, 2024 | 188,000.00 |
| Sep 30, 2024 | 203,000.00 |
| Jun 30, 2024 | 219,000.00 |
| Mar 31, 2024 | 237,000.00 |
| Dec 31, 2023 | 246,000.00 |
| Sep 30, 2023 | 258,000.00 |
| Jun 30, 2023 | 268,000.00 |
| Mar 31, 2023 | 417,000.00 |
| Dec 31, 2022 | 183,000.00 |
| Sep 30, 2022 | 981,000.00 |
| Jun 30, 2022 | 1.08 Mn |
| Mar 31, 2022 | 1.07 Mn |
| Dec 31, 2021 | 1.35 Mn |
| Sep 30, 2021 | 1.09 Mn |
| Jun 30, 2021 | 2.99 Mn |
API Access
Evofem Biosciences Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=EVFM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "EVFM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=EVFM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();